References
- Saloojee H, Coovadia H. Maternal age matters: for a lifetime, or longer [Internet]. Vol. 3, The Lancet Global Health. Elsevier Ltd; 2015. [cited 2020 Apr 15]. p. e342–3. Available from: http://www.ncbi.nlm.nih.gov/pubmed/25999095
- Poston L, Caleyachetty R, Cnattingius S, et al. Preconceptional and maternal obesity: epidemiology and health consequences. Lancet Diabetes Endocrinol. 2016;4(12):1025–1036. [Internet]. Dec 1 [cited 2020 Apr 15]Available from: https://linkinghub.elsevier.com/retrieve/pii/S2213858716302170
- , Metzger BE, Lowe LP, Dyer AR, et al. Hyperglycemia and adverse pregnancy outcomes. N Engl J Med. 2008;358(19):1991–2002.
- NICE. Diabetes in pregnancy: management from preconception to the postnatal period. 2015. Available from: https://www.nice.org.uk/guidance/ng3.
- Skolbekken JA. Shoulder dystocia–malpractice or acceptable risk? Acta Obstet Gynecol Scand. 2000;79(9):750–756.
- Ohno MS, Sparks TN, Cheng YW, et al. Treating mild gestational diabetes mellitus: a cost-effectiveness analysis. Am J Obstet Gynecol. 2011;205(3):282.e1–282–e7.
- International Association of Diabetes and Pregnancy Study Groups Recommendations on the Diagnosis and Classification of Hyperglycemia in Pregnancy. International Association Of Diabetes And Pregnancy Study Groups Consensus Panel; 2010; [cited 2019 May 4]. Available from: http://care.diabetesjournals.
- WHO. Diagnostic criteria and classification of hyperglycaemia first detected in pregnancy. 2013. Available from: https://www.who.int/diabetes/publications/Hyperglycaemia_In_Pregnancy
- Gardosi J, Chang A, Kalyan B, et al. Customised antenatal growth charts. Lancet. 1992;339(8788):283–287.
- NICE. Management of diabetes and its complications from pre-conception to the post natal period. 2008. Available from: https://www.nice.org.uk/guidance/cg63
- Rowan JA, Hague WM, Gao W, et al. Metformin versus insulin for the treatment of gestational diabetes. N Engl J Med. 2008;358(19):2003–2015.
- Crowther CA, Hiller JE, Moss JR, et al. Effect of treatment of gestational diabetes mellitus on pregnancy outcomes. N Engl J Med. 2005;352(24):2477–2486.
- Feig DS, Murphy K, Asztalos E, et al. Metformin in women with type 2 diabetes in pregnancy (MiTy): a multi-center randomized controlled trial. BMC Pregnancy Childbirth. 2016;16(1):173.
- Tarry-Adkins JL, Aiken CE, Ozanne SE. Neonatal, infant, and childhood growth following metformin versus insulin treatment for gestational diabetes: a systematic review and meta-analysis. Yang H, editor. PLOS Med. 2019;16(8):e1002848.
- Syngelaki A, Nicolaides KH, Balani J, et al. Metformin versus placebo in obese pregnant women without diabetes mellitus. N Engl J Med. 2016;374(5):434–443.
- Chiswick C, Reynolds RM, Denison F, et al. Effect of metformin on maternal and fetal outcomes in obese pregnant women (EMPOWaR): a randomised, double-blind, placebo-controlled trial. Lancet Diabetes Endocrinol. 2015;3(10):778–786.